Repeated  ||| S:0 E:9 ||| VBN
coagulation  ||| S:9 E:21 ||| JJ
testing  ||| S:21 E:29 ||| NN
in  ||| S:29 E:32 ||| IN
children ||| S:32 E:40 ||| NNS
.  ||| S:40 E:42 ||| .
Does  ||| S:42 E:47 ||| VBZ
it  ||| S:47 E:50 ||| PRP
improve  ||| S:50 E:58 ||| VB
the  ||| S:58 E:62 ||| DT
diagnostic  ||| S:62 E:73 ||| JJ
value ||| S:73 E:78 ||| NN
?  ||| S:78 E:80 ||| .
Mild  ||| S:80 E:85 ||| JJ
bleeding  ||| S:85 E:94 ||| NN
disorders  ||| S:94 E:104 ||| NNS
( ||| S:104 E:105 ||| -LRB-
BD ||| S:105 E:107 ||| NNP
)  ||| S:107 E:109 ||| -RRB-
such  ||| S:109 E:114 ||| JJ
as  ||| S:114 E:117 ||| IN
von  ||| S:117 E:121 ||| NNP
Willebrand  ||| S:121 E:132 ||| NNP
disease  ||| S:132 E:140 ||| NN
( ||| S:140 E:141 ||| -LRB-
VWD ||| S:141 E:144 ||| NNP
)  ||| S:144 E:146 ||| -RRB-
type  ||| S:146 E:151 ||| NN
I  ||| S:151 E:153 ||| PRP
are  ||| S:153 E:157 ||| VBP
often  ||| S:157 E:163 ||| RB
difficult  ||| S:163 E:173 ||| JJ
to  ||| S:173 E:176 ||| TO
diagnose  ||| S:176 E:185 ||| VB
because  ||| S:185 E:193 ||| IN
of  ||| S:193 E:196 ||| IN
inconclusive  ||| S:196 E:209 ||| JJ
laboratory  ||| S:209 E:220 ||| NN
results ||| S:220 E:227 ||| NNS
.  ||| S:227 E:229 ||| .
Our  ||| S:229 E:233 ||| PRP$
study  ||| S:233 E:239 ||| NN
examines  ||| S:239 E:248 ||| VBZ
the  ||| S:248 E:252 ||| DT
diagnostic  ||| S:252 E:263 ||| JJ
value  ||| S:263 E:269 ||| NN
of  ||| S:269 E:272 ||| IN
repeated  ||| S:272 E:281 ||| JJ
testing ||| S:281 E:288 ||| NN
.  ||| S:288 E:290 ||| .
Prospective  ||| S:290 E:302 ||| JJ
study  ||| S:302 E:308 ||| NN
on  ||| S:308 E:311 ||| IN
200  ||| S:311 E:315 ||| CD
children ||| S:315 E:323 ||| NNS
.  ||| S:323 E:325 ||| .
Extensive  ||| S:325 E:335 ||| JJ
laboratory  ||| S:335 E:346 ||| NN
testing  ||| S:346 E:354 ||| NN
was  ||| S:354 E:358 ||| VBD
done  ||| S:358 E:363 ||| VBN
twice  ||| S:363 E:369 ||| RB
and  ||| S:369 E:373 ||| CC
a  ||| S:373 E:375 ||| DT
standardized  ||| S:375 E:388 ||| JJ
history  ||| S:388 E:396 ||| NN
was  ||| S:396 E:400 ||| VBD
taken.  ||| S:400 E:407 ||| CD
165  ||| S:407 E:411 ||| CD
patients  ||| S:411 E:420 ||| NNS
completed  ||| S:420 E:430 ||| VBD
the  ||| S:430 E:434 ||| DT
study  ||| S:434 E:440 ||| NN
( ||| S:440 E:441 ||| -LRB-
median  ||| S:441 E:448 ||| JJ
age  ||| S:448 E:452 ||| NN
5.6  ||| S:452 E:456 ||| CD
years ||| S:456 E:461 ||| NNS
) ||| S:461 E:462 ||| -RRB-
.  ||| S:462 E:464 ||| .
Main  ||| S:464 E:469 ||| JJ
reason  ||| S:469 E:476 ||| NN
for  ||| S:476 E:480 ||| IN
referral  ||| S:480 E:489 ||| NN
was  ||| S:489 E:493 ||| VBD
aPTT  ||| S:493 E:498 ||| JJ
prolongation  ||| S:498 E:511 ||| NNS
( ||| S:511 E:512 ||| -LRB-
n  ||| S:512 E:514 ||| CD
=  ||| S:514 E:516 ||| SYM
109 ||| S:516 E:519 ||| CD
) ||| S:519 E:520 ||| -RRB-
.  ||| S:520 E:522 ||| .
The  ||| S:522 E:526 ||| DT
initial  ||| S:526 E:534 ||| JJ
diagnosis  ||| S:534 E:544 ||| NN
was  ||| S:544 E:548 ||| VBD
upheld  ||| S:548 E:555 ||| VBN
in  ||| S:555 E:558 ||| IN
74 ||| S:558 E:560 ||| CD
/ ||| S:560 E:561 ||| CD
165  ||| S:561 E:565 ||| CD
( ||| S:565 E:566 ||| -LRB-
44.8 ||| S:566 E:570 ||| NNP
% ||| S:570 E:571 ||| NN
)  ||| S:571 E:573 ||| -RRB-
children ||| S:573 E:581 ||| NNS
.  ||| S:581 E:583 ||| .
Of  ||| S:583 E:586 ||| IN
18  ||| S:586 E:589 ||| CD
patients  ||| S:589 E:598 ||| NNS
rated  ||| S:598 E:604 ||| VBN
normal ||| S:604 E:610 ||| JJ
,  ||| S:610 E:612 ||| ,
8  ||| S:612 E:614 ||| CD
had  ||| S:614 E:618 ||| VBD
to  ||| S:618 E:621 ||| TO
be  ||| S:621 E:624 ||| VB
reclassified  ||| S:624 E:637 ||| VBN
as  ||| S:637 E:640 ||| IN
possible  ||| S:640 E:649 ||| JJ
VWD  ||| S:649 E:653 ||| NN
later ||| S:653 E:658 ||| RBR
.  ||| S:658 E:660 ||| .
Ten  ||| S:660 E:664 ||| CD
patients  ||| S:664 E:673 ||| NNS
were  ||| S:673 E:678 ||| VBD
diagnosed  ||| S:678 E:688 ||| VBN
VWD  ||| S:688 E:692 ||| NNP
I.  ||| S:692 E:695 ||| NNP
In  ||| S:695 E:698 ||| IN
36  ||| S:698 E:701 ||| CD
patients  ||| S:701 E:710 ||| NNS
possible  ||| S:710 E:719 ||| JJ
VWD  ||| S:719 E:723 ||| NNP
was  ||| S:723 E:727 ||| VBD
found ||| S:727 E:732 ||| VBN
,  ||| S:732 E:734 ||| ,
13  ||| S:734 E:737 ||| CD
of  ||| S:737 E:740 ||| IN
these  ||| S:740 E:746 ||| DT
had  ||| S:746 E:750 ||| VBD
normal  ||| S:750 E:757 ||| JJ
results  ||| S:757 E:765 ||| NNS
at  ||| S:765 E:768 ||| IN
the  ||| S:768 E:772 ||| DT
second  ||| S:772 E:779 ||| JJ
visit  ||| S:779 E:785 ||| NN
while  ||| S:785 E:791 ||| IN
in  ||| S:791 E:794 ||| IN
6  ||| S:794 E:796 ||| CD
VWD  ||| S:796 E:800 ||| NNP
became  ||| S:800 E:807 ||| VBD
more  ||| S:807 E:812 ||| RBR
likely ||| S:812 E:818 ||| JJ
.  ||| S:818 E:820 ||| .
The  ||| S:820 E:824 ||| DT
main  ||| S:824 E:829 ||| JJ
diagnosis  ||| S:829 E:839 ||| NN
was  ||| S:839 E:843 ||| VBD
lupus-anticoagulant  ||| S:843 E:863 ||| JJ
( ||| S:863 E:864 ||| -LRB-
n=79 ||| S:864 E:868 ||| NNP
) ||| S:868 E:869 ||| -RRB-
,  ||| S:869 E:871 ||| ,
normalizing  ||| S:871 E:883 ||| VBG
in  ||| S:883 E:886 ||| IN
24 ||| S:886 E:888 ||| CD
.  ||| S:888 E:890 ||| .
A  ||| S:890 E:892 ||| DT
total  ||| S:892 E:898 ||| NN
of  ||| S:898 E:901 ||| IN
88  ||| S:901 E:904 ||| CD
children  ||| S:904 E:913 ||| NNS
underwent  ||| S:913 E:923 ||| VBD
surgery  ||| S:923 E:931 ||| NN
during  ||| S:931 E:938 ||| IN
the  ||| S:938 E:942 ||| DT
study  ||| S:942 E:948 ||| NN
period ||| S:948 E:954 ||| NN
.  ||| S:954 E:956 ||| .
Our  ||| S:956 E:960 ||| PRP$
study  ||| S:960 E:966 ||| NN
shows  ||| S:966 E:972 ||| VBZ
frequent  ||| S:972 E:981 ||| JJ
changes  ||| S:981 E:989 ||| NNS
in  ||| S:989 E:992 ||| IN
the  ||| S:992 E:996 ||| DT
diagnosis  ||| S:996 E:1006 ||| NN
and  ||| S:1006 E:1010 ||| CC
highlights  ||| S:1010 E:1021 ||| VBZ
the  ||| S:1021 E:1025 ||| DT
limitations  ||| S:1025 E:1037 ||| NNS
of  ||| S:1037 E:1040 ||| IN
single  ||| S:1040 E:1047 ||| JJ
laboratory  ||| S:1047 E:1058 ||| NN
tests  ||| S:1058 E:1064 ||| NNS
in  ||| S:1064 E:1067 ||| IN
detecting  ||| S:1067 E:1077 ||| VBG
mild  ||| S:1077 E:1082 ||| JJ
BD ||| S:1082 E:1084 ||| NNP
.  ||| S:1084 E:1086 ||| .
Clinical  ||| S:1086 E:1095 ||| JJ
and  ||| S:1095 E:1099 ||| CC
laboratory  ||| S:1099 E:1110 ||| NN
abnormalities  ||| S:1110 E:1124 ||| NNS
have  ||| S:1124 E:1129 ||| VBP
to  ||| S:1129 E:1132 ||| TO
be  ||| S:1132 E:1135 ||| VB
followed  ||| S:1135 E:1144 ||| VBN
and  ||| S:1144 E:1148 ||| CC
tests  ||| S:1148 E:1154 ||| NNS
must  ||| S:1154 E:1159 ||| MD
be  ||| S:1159 E:1162 ||| VB
repeated  ||| S:1162 E:1171 ||| VBN
in  ||| S:1171 E:1174 ||| IN
unclear  ||| S:1174 E:1182 ||| JJ
cases ||| S:1182 E:1187 ||| NNS
.  ||| S:1187 E:1189 ||| .
Normal  ||| S:1189 E:1196 ||| JJ
values  ||| S:1196 E:1203 ||| NNS
at  ||| S:1203 E:1206 ||| IN
one  ||| S:1206 E:1210 ||| CD
point  ||| S:1210 E:1216 ||| NN
do  ||| S:1216 E:1219 ||| VBP
not  ||| S:1219 E:1223 ||| RB
exclude  ||| S:1223 E:1231 ||| VB
a  ||| S:1231 E:1233 ||| DT
BD ||| S:1233 E:1235 ||| NNP
.  ||| S:1235 E:1237 ||| .
